Gold nanoprobe-based method for sensing activated leukocyte cell adhesion molecule (ALCAM) gene expression, as a breast cancer biomarker
Source abstract
Abstract
In breast cancer, a proper biomarker for the assessment of metastasis and poor prognosis is the RNA of activated leukocyte cell adhesion molecule (ALCAM) gene, which is expressed at high levels in breast tumor. We applied DNA-functionalized gold nanoparticles as the target-specific probes, for detecting specific sequences of DNA or RNA. At high MgCL2 concentrations, nanoprobes aggregate in the absence of the complementary DNA sequence and alteration in the solution color is detectable by evaluating the localized surface plasmon resonance (LSPR). But in the presence of complementary DNA, nanoprobes hybridize to the complementary sequence; therefore, no aggregation takes place, and no color change is observed. We designed a gold nanoprobe-based method that promptly detects the ALCAM gene expression in a low reaction volume with high sensitivity and specificity. This method is simple, fast, selective, and quantitative and can be done with small concentrations of the target (fmol/μL). Limit of detection of the method corresponded to 300 fmol/μL of synthetic ALCAM target.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medical Biotechnology, Tabriz University of Medical Sciences, Tabriz, Iran;
Department of Medical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran;
Tuberculosis and Lung Disease Research Center of Tabriz, Tabriz University of Medical Sciences, Tabriz, Iran;
Immunology Research Center Tabriz University of Medical Sciences, Tabriz, Iran
References (28)
Show source-provided references
1. 10.3109/21691401.2014.92788010.3109/21691401.2014.927880 ↗
2. 10.1373/clinchem.2005.06539110.1373/clinchem.2005.065391 ↗
3. 10.1002/mabi.20060007510.1002/mabi.200600075 ↗
4. 10.1021/bp050142310.1021/bp0501423 ↗
5. 10.1007/s11051-013-1930-910.1007/s11051-013-1930-9 ↗
6. 10.1186/1477-3155-8-510.1186/1477-3155-8-5 ↗
7. 10.3109/21691401.2015.103190510.3109/21691401.2015.1031905 ↗
8. 10.3322/caac.2120310.3322/caac.21203 ↗
9. 10.1038/mt.2014.3010.1038/mt.2014.30 ↗
10. Doria G, Franco R, Baptista P. 2007. Nanodiagnostics: fast colorimetric method for single nucleotide polymorphism/mutation detection. IET Nanobiotechnol. 1:53–57.10.1049/iet-nbt:20070001 ↗
11. 10.3109/21691401.2014.92256810.3109/21691401.2014.922568 ↗
12. 10.1109/LAWP.2010.204381010.1109/LAWP.2010.2043810 ↗
13. 10.1021/nn900002m10.1021/nn900002m ↗
14. 10.1155/2010/81250910.1155/2010/812509 ↗
15. 10.1097/JTO.0b013e31824af2db10.1097/JTO.0b013e31824af2db ↗
16. Jezierska A · Med Sci Monitor Basic Res. · 2006 · 12 · BR263
17. 10.1016/j.canlet.2014.02.00610.1016/j.canlet.2014.02.006 ↗
18. 10.1039/C5RA09872F10.1039/C5RA09872F ↗
19. 10.2116/analsci.31.11310.2116/analsci.31.113 ↗
20. 10.3390/cancers201019010.3390/cancers2010190 ↗
21. 10.1021/la102613f10.1021/la102613f ↗
22. 10.1007/s11033-011-0783-510.1007/s11033-011-0783-5 ↗
23. 10.1049/mnl.2014.006310.1049/mnl.2014.0063 ↗
24. 10.1109/TNB.2014.236525610.1109/TNB.2014.2365256 ↗
25. 10.1039/C1CS15238F10.1039/C1CS15238F ↗
26. 10.1159/00033722210.1159/000337222 ↗
27. 10.5604/17322693.117716910.5604/17322693.1177169 ↗
28. 10.1007/s10549-011-1365-x10.1007/s10549-011-1365-x ↗